Holen Sie sich die Stockscreener-App
7.45
6.58%
0.46
Handel nachbörslich:
7.42
-0.03
-0.40%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt NVAX?
Forum
Prognose
Aktiensplit
Novavax Inc Aktie (NVAX) Neueste Nachrichten
Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Investor Network: Novavax, Inc to Host Earnings Call - ACCESS Newswire
July 25th Options Now Available For Novavax (NVAX) - Nasdaq
LigaChem Biosciences adopts U.S. Novavax technology for next-gen ADCs - Chosunbiz
Moderna's New COVID Vaccine Secures FDA-Clearance For Seniors, At-Risk Individuals - Benzinga
Novavax (NVAX) Sees Surge in Bullish Option Activity | NVAX Stoc - GuruFocus
US CDC continues to recommend COVID vaccines for children, contradicts Kennedy - marketscreener.com
Novavax (NVAX) Sees Surge in Bullish Option Activity | NVAX Stock News - GuruFocus
RFK Jr. Drops COVID Vaccine Recommendation For Healthy Kids, But Experts Warn Of Major Risks - Benzinga
Novavax to Participate in Upcoming Investor Conferences - Quantisnow
Novavax to Participate in Upcoming Investor Conferences | NVAX S - GuruFocus
Novavax Announces June Presentations at Jefferies and Goldman Sachs Conferences | NVAX Stock News - Stock Titan
Novavax Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Novavax eliminates COO role, parts ways with longtime exec amid business model shift - The Business Journals
(NVAX) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
Novavax Eliminates COO Position, Trizzino to Consult - TipRanks
Novavax IncEliminates COO Position, Terminates John TrizzinoSEC Filing - marketscreener.com
Here's Why Novavax (NVAX) is a Strong Momentum Stock - Yahoo Finance
Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Novavax COVID-19 vaccine approved by the FDA - MSN
Gaithersburg-Based Novavax Receives FDA Approval for COVID-19 Vaccine for High-Risk Groups - The MoCo Show -
JPMorgan Maintains Underweight Rating on Novavax (NVAX) Stock Despite Positive News - MSN
Novavax Target of Unusually High Options Trading (NASDAQ:NVAX) - Defense World
BofA Reiterates Hold Rating on Novavax (NVAX) Stock - MSN
Analysts Think These Stocks Could More Than Double in Value - MarketBeat
Rx Rundown: BioMarin, Novavax, CellCentric and more - Medical Marketing and Media
Novavax, Inc. (NASDAQ:NVAX) Given Average Rating of “Hold” by Analysts - Defense World
NVAX Stock Surges on Securing FDA Approval for COVID-19 Vaccine - MSN
NVAX July 3rd Options Begin Trading - Nasdaq
Biotech Stock Roundup: BMRN to Acquire INZY, NVAX Gains on Vaccine Approval & More - Yahoo Finance
New Vaccine Framework Avoided Worst-Case Scenario, Analysts Say - insights.citeline.com
Novavax: Nuvaxovid FDA Approval Unlocks Several Bullish Stimuli (NASDAQ:NVAX) - Seeking Alpha
Novavax Soars After Covid Vaccine Secures Full FDA Approval - MSN
Novavax Stock (NVAX) Shoots 15% Higher as Covid Vaccine Jab Gets FDA Green Light - The Globe and Mail
US FDA advisers to consider if new COVID shots should target LP.8.1 subvariant - marketscreener.com
Novavax, Inc. (NASDAQ:NVAX) Shares Fly 29% But Investors Aren't Buying For Growth - simplywall.st
BTIG Maintains a Buy rating on Novavax (NVAX) - Insider Monkey
Dow Surges Over 100 Points Despite Moody's US Downgrade: Fear Index Remains In 'Greed' Zone - Benzinga
US Markets Show Mixed Signals Amid Rating Downgrades And Rising Earnings - Finimize
Novavax Receives FDA Approval for Nuvaxovid Vaccine for High-Risk Populations - madisongraph.com
Novavax’s COVID-19 Vaccine Label Narrowed After Political Officials Intervened - insights.citeline.com
Novavax gets FDA nod for Nuvaxovid vaccine in high-risk groups By Investing.com - Investing.com South Africa
JPMorgan maintains Novavax stock Underweight with $7 target By Investing.com - Investing.com Nigeria
FDA Clears Novavax, Inc. (NVAX)’s COVID-19 Vaccine with Usage Restrictions - MSN
Third COVID Vaccine Gets Approved for Adults 65 and Over - AARP
These Stocks Moved the Most Today: Nvidia, Tesla, UnitedHealth, JPMorgan, SMCI, Palantir, Novavax, and More - Barron's
With FDA vaccine nod, Novavax takes ACIP of new COVID-19 rules - BioWorld MedTech
FDA Approval Boosts Novavax (NVAX) with $200M Milestone | NVAX S - GuruFocus
Novavax, Shake Shack, solar stocks: Trending Tickers - Yahoo Finance
Novavax gets FDA nod for Nuvaxovid vaccine in high-risk groups - Investing.com Australia
Novavax Shares Jump 17% FDA Grants Full Approval to COVID Vaccine - Yahoo Finance
Stocks Mixed, Treasury Bonds Slip On Moody's US Downgrade: What's Driving Markets Monday? - Benzinga
US Approves Novavax Covid Jab After Delay, Adds Restrictions - Barron's
1.21%
1.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):